Parkinson's Disease Trial, Not Yet Recruiting NCT06028477 Sponsor: Stanford University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06028477
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 or older
  • People who have been diagnosed with idiopathic Parkinson's Disease (a form of Parkinson's where no specific external cause has been identified)
  • People who are fluent in English
  • People whose Parkinson's motor symptoms, measured during an "off" period (when medication is less effective), scored at least 30 on a standard assessment scale within the past 6 months or at the initial screening visit (confirm with trial site)
  • People who understand what the study involves and are willing to sign a consent form and complete all required study procedures

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking part in, or have taken part in, another clinical trial involving a drug, device, or biological treatment within the past 30 days
  • People who are pregnant, breastfeeding, or planning to become pregnant
  • People who have physical limitations unrelated to Parkinson's Disease that could affect movement-related assessments
  • People who have a medical device already implanted in their body
  • People who have abnormal sensation or feeling in their fingertips

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vivek P Buch, MD, Stanford University

Phone: 650-474-9547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 January 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in MDS-Unified Parkinson's Disease Rating Scale Part III Scale Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov